AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2023
Feb 24, 2023
34129_dirs_2023-02-24_8f19f4de-be76-44c7-8e1e-ef1a8ebc0cb2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2023-02-22
Reporting Person: Bonvini Ezio (Sr VP, Research & CSO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-22 | Common Stock | M | 9375 | — | Acquired | 123799 | Direct |
| 2023-02-22 | Common Stock | F | 3619 | $6.55 | Disposed | 120180 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-22 | Restricted Stock Unit | $0.0 | M | 9375 | Disposed | Common Stock (9375.0) | Direct |
Footnotes
F1: On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis.
More from MACROGENICS INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18